New Jersey Attorneys Who Get Results

New Jersey Attorney, New Jersey Medical Malpractice Attorney, NJ Personal Injury Lawyers

Meet Gary Shapiro and David Sternlieb, two experienced New Jersey attorneys who know how to get results. At Shapiro & Sternlieb, we are 100% dedicated to providing our clients with the highest quality legal representation. Through our hard work, persistence and with more than 60 years of combined legal experience, we work hard to protect your rights. As expert lawyers, we have the resources and knowledge to handle complex cases. We pride ourselves on our concern for you as an individual as well as for your legal rights.

Shapiro & Sternlieb: New Jersey Personal Injury Lawyers

auto accident lawyer ,NJ Personal Injury Lawyers, New Jersey Medical Malpractice Attorney

At Shapiro & Sternlieb, your case is our priority. Our attorneys combine outstanding client services with a thorough knowledge of the law and a firm understanding of the latest technology available. Our vast network of legal, medical and professional experts are available to present the best case for you. Located in Manalapan, New Jersey, our lawyers maintain flexible hours to meet your needs. We offer morning, evening or weekend hours, as well as visits to home or hospital, if needed. Our attorneys and staff bring the highest standards of expertise, preparation, concern, diligence, integrity and skill to each case. We take time to return your calls and to ensure each question is answered. You are included every step of the way!

News & Articles


Salmonella Outbreak Linked To Tainted Peanut Butter
CARBON NANOTUBES: A Closer Look at Miracle Technology's Potential Side Effects

Practice Areas

AsbestosInfant & Child Injuries
Auto AccidentsDUI (DWI) Matters
DiscriminationBirth Injuries
Defective ProductsBrain Injury
Burn InjuriesCerebral Palsy
Criminal DefenseClass Action Lawsuits
Construction AccidentsDog Bites
Erbs PalsyFailure To Diagnose Cancer
Gas ExplosionsHead Injury
Juvenile CourtLung Cancer - Mesothelioma
Medical MalpracticeMotorcycle Accidents
NegligenceNegligent Security
Nursing Home AbusePersonal Injury
Premises LiabilitySexual Harassment
Slip & Fall AccidentsTraffic Violations
Truck AccidentsWorkplace Injuries
Wrongful Discharge

FDA Consumer Health Information Updates

http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

What to Ask Your Doctor Before Taking Opioids


Thu, 19 Jan 2017 09:00:00 -0500

Opioids can be used to treat certain kinds of chronic and acute pain. It doesn't matter who is writing the prescription; ask these questions before taking opioids.

Is It Really 'FDA Approved?'


Tue, 17 Jan 2017 08:00:00 -0500

How can you know for sure what the U.S. Food and Drug Administration regulates? FDA is responsible for protecting the public health by regulating human drugs and biologics, animal drugs, medical devices, tobacco products, food and animal feed, cosmetics, and products that emit radiation.

Help Keep a Sick Child Safe: Learn How to Use a Hospital Crib


Thu, 12 Jan 2017 08:00:00 -0500

It's important that you know how to use medical cribs and bassinets correctly, both in and out of the hospital -- especially if your special needs child uses one of these cribs at home.

FDA Encourages More Participation, Diversity in Clinical Trials


Tue, 10 Jan 2017 08:00:00 -0500

The FDA is encouraging more people--including members of diverse racial and ethnic groups, women, and older adults--to participate in clinical trials. Learn why.

Adding Folic Acid to Corn Masa Flour May Prevent Birth Defects


Wed, 04 Jan 2017 08:15:00 -0500

When consumed by women before and during pregnancy, folic acid, a B vitamin, may help prevent neural tube defects (NTDs).


Food and Drug Administration--Press Releases

http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/PressReleases/rss.xml

FDA approves Trulance for Chronic Idiopathic Constipation


Thu, 19 Jan 2017 16:04:00 -0500

The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.

Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch


Thu, 19 Jan 2017 09:03:00 -0500

Today the U.S. Food and Drug Administration is establishing the Oncology Center of Excellence (OCE) and appointing Dr. Richard Pazdur as its director. This will make oncology the first disease area to have a coordinated clinical review of drugs, biologics and devices across the agency’s three medical product centers.

Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical product communications


Wed, 18 Jan 2017 09:24:00 -0500

We recognize that there is a high level of interest regarding FDA’s views on communications about medical products. We are committed to an ongoing dialogue with industry and other stakeholders, and, when needed, providing guidance to clarify the agency’s thinking on these issues. Today, the FDA released two separate draft guidances that will each help provide clarity for medical product companies, as well as other interested parties, on FDA’s current thinking and recommendations for a few different types of communications about medical products.

FDA and EPA issue final fish consumption advice


Wed, 18 Jan 2017 09:04:00 -0500

Today, the U.S. Food and Drug Administration and the U.S. Environmental Protection Agency issued final advice regarding fish consumption. This advice is geared toward helping women who are pregnant or may become pregnant – as well as breastfeeding mothers and parents of young children – make informed choices when it comes to fish that are healthy and safe to eat. (This advice refers to fish and shellfish collectively as “fish.”)

FDA approves first drug for spinal muscular atrophy


Fri, 23 Dec 2016 16:39:00 -0500

The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement. Spinraza is an injection administered into the fluid surrounding the spinal cord.


Recall Listing

https://www.cpsc.gov/Recalls?field_rc_date_value[min]&field_rc_date_value[max]&field_rc_heading_value=&field_rc_hazard_description_value=&field_rc_manufactured_in_value=&field_rc_manufacturers_value=


nnn